GO
Loading...

Looking to JAZZ Up Your Portfolio?

Friday, 7 Jun 2013 | 6:25 PM ET

Jazz Pharmaceuticals' stock has roared, says Mad Money host Jim Cramer. The company gets 69 percent of its sales from its narcolepsy drug Xyrem which has a wall of patents protecting the drug from competition.